Samsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Vial Across Europe, to Treat Ophthalmic Conditions
-
29/03/2026, 08:01
-
ansa.it
0
Scopri altro
- 29/05/2026, 08:01
-
ansa.it
-
0
- 29/05/2026, 07:46
-
ansa.it
-
0
- 29/05/2026, 05:02
-
ansa.it
-
0
- 29/05/2026, 03:17
-
ansa.it
-
0
- 29/05/2026, 02:19
-
ansa.it
-
0
- 29/05/2026, 01:47
-
ansa.it
-
0
- 29/05/2026, 01:34
-
ansa.it
-
0
Nessun commento